USFDA Approved Latest Drug for Lung Cancer Patients
Beacon Pharmaceuticals Limited, the leading oncology company in Bangladesh, has introduced a groundbreaking treatment for lung cancer: Tagrix, the first global generic version of osimertinib.
Learn more
Global patient safety
The safety and efficacy of BEACON's products have been verified by physicians abroad through observational studies on cancer patients. We practice pharmacovigilance, highlighting our company's commitment to quality during the production of finished pharmaceutical products.
Transforming healthcare system in lower-income populations
Our mission goes beyond medicines. We're dedicated to transforming healthcare system in lower-income populations, ensuring equitable access to quality healthcare because we are here for you.
Watch Video